A survey to determine the blood concentration of cyclosporine 2 hours postdose in stable renal transplant patients

Transplantation Proceedings

Volumn 36, Issue 10, 2004, Pages 3239-3241

  Jorga, Anamarija ^a   Holt, D W ^a   Yaqoob, M ^a   Whittaker, C ^a   Johnston, A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CREATININE; IMMUNOSUPPRESSIVE AGENT;

BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MONITORING; GRAFT REJECTION; HEALTH SURVEY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; ARTICLE; BLOOD; IMMUNOLOGY; METHODOLOGY; PHYSIOLOGY; TIME;

CREATININE; CYCLOSPORINE; DRUG MONITORING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; TIME FACTORS;

EID: 21244465172     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.10.077     Document Type: Article

References (14)

1. Jorga A, Holt DW, Johnston A: Therapeutic drug monitoring of cyclosporine. Transplant Proc 36(Suppl):396S, 2004
2. Belitsky P, Levy GA, Johnston A: Neoral absorption profiling: an evolution in effectiveness. Transplant Proc 32(Suppl):45S, 2000
3. Johnston A, David OJ, Cooney GF: Pharmacokinetic validation of neoral absorption profiling. Transplant Proc 32(Suppl):53S, 2000
4. Cole E, Midtvedt K, Johnston A, et al: Recommendations for the implementation of Neoral C(2) monitoring in clinical practice. Transplantation 73(Suppl):S19, 2002
5. Levy G: C2 monitoring in liver transplantantation with Neoral immunosuppresion: effect of achieving C2 target early on efficacy and safety. Am J Transplant 1(Suppl 1):419, 2001
6. Levy G, Burra P, Cavallari A, et al: Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2). Transplantation 73:953, 2002
7. Cole E, Maham N, Cardella C, et al: Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients. Transplantation 75:2086, 2003
8. Cooney GF, Johnston A: Neoral C-2 monitoring in cardiac transplant patients. Transplant Proc 33:1572, 2001
9. Thervet E, Pfeffer P, Scolari MP, et al: Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion. Transplantation 76:903, 2003
10. ISO5725: 1994 accuracy (trueness and precision) of measurement methods and results. London: BSI Group; 1994
11. Midtvedt K, Fauchald P, Bergan S, et al: C2 monitoring in maintenance renal transplant recipients: is it worthwhile? Transplantation 76:1236, 2003
12. Grevel J, Welsh MS, Kahan BD: Cyclosporine monitoring in renal transplantation: area under the curve monitoring is superior to trough-level monitoring. Ther Drug Monit 11:246, 1989
13. Keown PA: New concepts in cyclosporine monitoring. Curr Opin Nephrol Hypertens 11:619, 2002
14. Jorga A, Johnston A, Holt DW: Patient management by cyclosporine C2 monitoring. Transplantation 77:323, 2004